All implanted medical devices stimulate collagen deposition resulting in a surrounding fibrotic capsule. Implants are frequently used for reconstruction, such as breast implants following mastectomy. The most common complication following breast implants is capsular fibrosis (CF), with its severity clinically measured by the Baker I-IV classification. Despite the clinical prevalence, the mechanisms underlying CF are still poorly understood and therapeutic interventions are limited. For the first time, we analyze human capsule samples to identify the pathways activated in human capsular fibrosis, and use animal models to clarify the mechanisms underlying the fibrotic process resulting in CF.
RESULTS:
1,543 genes were upregulated and 1,016 were downregulated in Baker IV vs Baker I. Interestingly, genes regulating macrophage activation, macrophage surface markers and extracellular matrix (ECM) production were among the most highly expressed in Baker IV specimens. Conversely, we did not observe significant increases in myofibroblast genes. To determine whether our findings in the human fibrotic tissues were similar to murine capsules we used vav-reporter-mice for lineage tracking. Here we observed the recruitment of mainly immune cells in fibrotic capsule development and identified the presence of a hematopoietic-derived cell with distinct characteristics of macrophages, confirming their existence within the chronology of CF. To confirm this, we placed silicone implants into Bl6-mice. Surprisingly, in the murine capsules we found the predominant cells across different time-points were myeloid cells and not fibroblasts or endothelial cells. We were able to confirm that these macrophages could produce ECM at the protein level by subjecting the cells to FACS analysis. We found over 80% of the macrophages expressing collagen 1. Our findings were confirmed by analysis of immunohistochemistry stains of the fibrotic sections showing that F4/80+ macrophages deposited collagen.
CONCLUSION:
For the first time we demonstrate that collagen depositingmacrophages are responsible for CF by analyzing both patient samples and murine models. Taken together, our findings suggest that macrophages seem to be one of the predominant sources of ECM deposition in fibrotic capsules and may have promising therapeutic implications for the treatment of CF. 
PURPOSE:
The vascularized omental free flap has been described as a reliable option for the treatment of peripheral lymphedema. However, the flap is a high-pressure system that may require venous supercharging or intra-flap AV fistula in order to offload the arterial inflow. The aim of this study is to introduce and present our experience using a flow-through omental flap as a novel approach to minimize the arterial inflow while maximizing venous outflow.
METHODS:
A retrospective review of a prospectively maintained quality improvement (QI) database was performed. Consecutive patients with unilateral breast-cancer related lymphedema (BCRL) who underwent delayed lymphatic reconstruction using a flow through omental free flap were identified. Patient characteristics and intraoperative specifics were retrieved.
RESULTS:
Five consecutive patients underwent a free omental flap by a single surgeon from January 2018 to September 2018. All patients were female with a mean age of 59.6 (41-73) years and BMI of 28.8 (25.1-32.3) kg/ m 2 . All patients were classified with stage II lymphedema using the International Lymphedema Staging (ILS) criteria. Mean flap weight was 30 (22-40) grams and mean number of lymph nodes transferred detected by intraoperative ultrasound was 7.6 (6-11). In all patients, the right gastroepiploic artery and vein were anastomosed to the proximal end of the radial artery and to one vena comitante, respectively. An anastomosis of the distal end of the radial artery to the left gastroepiploic artery was performed. The intervening segment of the native radial artery was removed. The flap was then supercharged by anastomosing the left gastroepiploic vein to the cephalic vein. All patients followed the standard protocol for postoperative care at our institution. There were no flap losses or peri-operative complications.
CONCLUSION:
The flow-through omental free flap to the forearm should be considered as a reliable surgical option for patients with upper extremity BCRL. A distinct advantage of this inset includes moderating the arterial in-flow into the inherent high-pressure environment of the omental flap to avoid an inflow-outflow mismatch. Further study is needed to validate this technique in a larger study sample with longer follow-up.
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Anti α-Gal Nanoparticles Ameliorate Radiation-Induced Wound Healing Impairment 
Arash Samadi

PURPOSE:
Radiation is a common primary, adjuvant and neoadjuvant therapy in oncological patients, resulting in damage to the local tissues and permanently compromised wound healing. As a result, surgery in radiated tissue is known to have significantly higher rates of complications. It is thought that one cause of impaired wound healing is the aberrant inflammatory response that occurs in radiated tissues. Humans are continually and safely exposed to the natural antigen α-gal (Galalpha1-3Galbeta1-(3)4GlcNAc-R), and 1% of their antibodies are directed against the antigen. We have previously demonstrated that the topical application of α-gal nanoparticles can significantly accelerate wound healing in both normal and diabetic wounds likely due to accelerated macrophage recruitment. We hypothesized that application of α-gal nanoparticles would similarly enhance wound healing in irradiated wounds.
METHODS:
Since mice normally produce the antigen α-gal, α-1,3galactosyltrasferase knockout mice (which do not produce the antigen and therefore can be stimulated to produce antibodies against it) were used in all experiments. Mice were immunized to produce anti α-gal antibodies at titers comparable to those seen in humans. Dorsal skin was isolated using a low-pressure clamp as previously described and was treated with one session of 40Gy. Ten days after radiation two 6-mm bilateral dorsal splinted wounds were created, and these were then treated with α-gal nanoparticles in a 2% carboxymethyl cellulose (CMC) carrier, immediately after wounding and again on postoperative day 1. Control wild type and knockout mice underwent similar irradiation and wounding protocols but were treated with phosphate buffered saline (PBS) in 2% CMC. Wounds were harvested from all animals on days 3, 6, 9, 12 and 15, fixed, sectioned, and H&E and IHC performed to determine the extent of keratinocyte migration, granulation tissue deposition, neovascularization and macrophage invasion.
RESULTS:
Full closure of all wounds by day 9 in the non-radiated control compared to no completely closed wounds in the radiated group confirmed the known inhibitory effects of irradiation on wound healing. In addition, histological changes such as increased epidermal thickness in the tissue surrounding the wound further confirmed the effects of irradiation on the skin. Histologic analysis demonstrated significantly enhanced keratinocyte migration in the α-gal nano-particle treated group by day 15 in comparison to saline treated group (2.37mm versus 0.58mm, p<0.001). Fifteen days after wounding 25% of all α-gal treated wounds were completely healed as oppose to only 10% in the saline treated group. Analysis of later time points is currently underway.
CONCLUSION:
Topical application of α-gal nanoparticles onto radiated wounds significantly accelerates the rate and degree of wound closure. We believe this naturally occurring agent has great promise for translation in plastic surgery as it has demonstrated efficacy in not only
